THE Health Department yesterday published a summary of the April 2017 cycle of price disclosure reductions, which involve the "second remove originator" changes.
Reductions range from 28.54% for Risperidone through to a hefty 84.74% for Pemetrexed powder for injection, while Rosuvastatin will have a 35.42% reduction applied.
The full list of impacted drugs can be viewed at pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Dec 16
